BioNTech’s Bold Pivot: From COVID-19 Savior to Cancer Combatant
BioNTech faces a pivotal transition from COVID-19 vaccine success to focusing on cancer therapies using mRNA technology. Diminishing demand for COVID-19 vaccines has impacted BioNTech's financial performance, with revenue dropping…